Clinical Trial: 18F-Fluciclovine PET-MRI in High-grade Glioma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Glioma
Study Type: INTERVENTIONAL
Official Title: Evaluation of 18F-Fluciclovine PET-MRI to Differentiate Tumor Progression From Post-treatment Changes in Pediatric High-grade Glioma (HGG)
Brief Summary:
The purpose of this study is to see if 18F-fluciclovine (Axumin®) PET imaging is useful and safe in the management of children with High Grade Gliomas.Investigators seek to determine if this imaging will help doctors tell the difference between tumor growth (progression) and other tumor changes that can occur after treatment.
Read more